Here are eight things to know:
1. The company signed eight contracts to distribute LOQTEQ products with non-stocking distributors.
2. Under these agreements, the distributors will cover different regions in California, Texas, Ohio, Tennessee, Oklahoma and Utah.
3. aap Implantate is banking in the United States on a hybrid distribution model, selling LOQTEQ products locally via stocking and non-stocking distributors.
4. The company has built the necessary infrastructure to distribute LOQTEQ in the United States, including setting up a U.S. distribution company and deciding all distribution activities will be managed by an experienced sales director.
5. The company signed an agreement with a logistics service provider responsible for the logistics of products to distributors and hospitals.
6. The company’s next steps include providing inventories and product training courses for the distributors’ sales employees.
7. The company plans to step up its presence at the leading relevant trade shows and events in the United States.
8. aap Implantate is still seeking distributor partnerships in the coming months and plans to intensify distribution activities.
More articles on orthopedic devices:
10 trends to note in the knee implant market
8 trends in the North American neurosurgery market
5 predictions about the 2012-2018 bio-implant market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
